Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 10, 2011, Pages 4844-4849

  Esterly, John S ^a,c   Griffith, Milena ^b,c   Qi, Chao ^c   Malczynski, Michael ^c   Postelnick, Michael J ^c   Scheetz, Marc H ^b,c  

^a CHICAGO STATE UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; POLYMYXIN;

ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CONTROLLED STUDY; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CARBAPENEMS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMYXINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80052846857     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01728-10     Document Type: Article

References (34)

1. Abbo, A., Y. Carmeli, S. Navon-Venezia, Y. Siegman-Igra, and M. J. Schwaber. 2007. Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes. Eur. J. Clin. Microbiol. Infect. Dis. 26:793-800.
2. Adams, M. D., E. R. Chan, N. D. Molyneaux, and R. A. Bonomo. 2010. Genomewide analysis of divergence of antibiotic resistance determinants in closely related isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:3569-3577.
3. American Journal of Kidney Disease. 2002. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39:S1-S266.
4. Bellomo, R., C. Ronco, J. A. Kellum, R. L. Mehta, and P. Palevsky. 2004. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care 8:R204-R212.
5. Bonomo, R. A., and D. Szabo. 2006. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43(Suppl. 2):S49-S56.
6. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing, p. M100-S19. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Falagas, M. E., I. A. Bliziotis, and I. I. Siempos. 2006. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit. Care 10:R48.
8. Falagas, M. E., S. K. Kasiakou, P. I. Rafailidis, G. Zouglakis, and P. Morfou. 2006. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy. J. Antimicrob. Chemother. 57:1251-1254.
9. Grupper, M., H. Sprecher, T. Mashiach, and R. Finkelstein. 2007. Attributable mortality of nosocomial Acinetobacter bacteremia. Infect. Control Hosp. Epidemiol. 28:293-298.
10. Hamouda, A., B. A. Evans, K. J. Towner, and S. G. Amyes. 2010. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J. Clin. Microbiol. 48:2476-2483.
11. Harbarth, S., V. Nobre, and D. Pittet. 2007. Does antibiotic selection impact patient outcome? Clin. Infect. Dis. 44:87-93.
12. Héritier, C., L. Poirel, D. Aubert, and P. Nordmann. 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother. 47:268-273.
13. Kim, Y. A., et al. 2008. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter. Scand. J. Infect. Dis. 40:234-240.
14. Kwon, K. T., et al. 2007. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J. Antimicrob. Chemother. 59:525-530.
15. Lautenbach, E., et al. 2009. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect. Control Hosp. Epidemiol. 30: 1186-1192.
16. Livermore, D. M., et al. 2010. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int. J. Antimicrob. Agents 35:19-24.
17. Lolans, K., T. W. Rice, L. S. Munoz-Price, and J. P. Quinn. 2006. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob. Agents Chemother. 50:2941-2945.
18. Markogiannakis, A., et al. 2008. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect. Control Hosp. Epidemiol. 29:410-417.
19. Metan, G., F. Sariguzel, and B. Sumerkan. 2009. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia. Eur. J. Intern. Med. 20:540-544.
20. Munoz-Price, L. S., et al. 2010. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect. Control Hosp. Epidemiol. 31:1057-1062.
21. Naas, T., F. Namdari, H. Reglier-Poupet, C. Poyart, and P. Nordmann. 2007. Panresistant extended-spectrum beta-lactamase SHV-5-producing Acinetobacter baumannii from New York City. J. Antimicrob. Chemother. 60:1174-1176.
22. Perez, F., et al. 2010. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J. Antimicrob. Chemother. 65:1807-1818.
23. Qi, C., M. Malczynski, M. Parker, and M. H. Scheetz. 2008. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J. Clin. Microbiol. 46:1106-1109.
24. Robenshtok, E., et al. 2006. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J. Hosp. Infect. 64:282-287.
25. Rossolini, G. M., E. Mantengoli, J. D. Docquier, R. A. Musmanno, and G. Coratza. 2007. Epidemiology of infections caused by multiresistant gramnegatives: ESBLs, MBLs, panresistant strains. New Microbiol. 30:332-339. (Pubitemid 47264901)
26. Routsi, C., et al. 2010. Carbapenem-resistant versus carbapenem- susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38:173-180.
27. Saleem, A. F., I. Ahmed, F. Mir, S. R. Ali, and A. K. Zaidi. 2010. Panresistant Acinetobacter infection in neonates in Karachi, Pakistan. J. Infect. Dev. Ctries. 4:30-37.
28. Scheetz, M. H., et al. 2009. Morbidity associated with Pseudomonas aeruginosa bloodstream infections. Diagn. Microbiol. Infect. Dis. 64:311-319.
29. Schreckenberger, P. C., D. M. Celig, and W. M. Janda. 1988. Clinical evaluation of the Vitek ANI card for identification of anaerobic bacteria. J. Clin. Microbiol. 26:225-230.
30. Sheng, W. H., et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int. J. Infect. Dis. 14:e764-e769.
31. Sun, G. W., T. L. Shook, and G. L. Kay. 1996. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J. Clin. Epidemiol. 49:907-916.
32. Sunenshine, R. H., et al. 2007. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 13:97-103.
33. Tenover, F. C., et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
34. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.